Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-10-003834
Filing Date
2010-07-06
Accepted
2010-07-06 19:00:43
Documents
1
Period of Report
2010-07-01

Document Format Files

Seq Description Document Type Size
1 c62123_ex.html 4  
1 c62123_ex.xml 4 7173
  Complete submission text file 0000930413-10-003834.txt   9113
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
SALISBURY ROBERT C (Reporting) CIK: 0001185468 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 10940629